Symmetric-breaking strategy has broadly applied in organic photovoltaic material design while a comprehensive understanding of the effects of two dimension (2D) asymmetric side chains in all-small-molecule organic solar cells (ASM-OSCs)...
Among all‐inorganic perovskite photoactive materials, CsPbIBr2 demonstrates the most balanced trade‐off between optical bandgap and phase stability. However, the poor quality and high‐temperature engineering of CsPbIBr2 film hinder the further optimization of derived perovskite solar cells (PSCs). Herein, a simple dynamic vacuum‐assisted low‐temperature engineering (merely 140 °C) is proposed to prepare high‐quality CsPbIBr2 film (VALT‐CsPbIBr2 film). Compared to HT‐CsPbIBr2 film processed via conventionally high temperature (280 °C), VALT‐CsPbIBr2 film presents higher crystallinity and more full coverage consisting of larger grains and fewer grain boundaries, which results in intensified light‐harvesting capability, reduced defects, and extended charge carrier lifetime. Benefiting from those improved merits, VALT‐CsPbIBr2 PSCs show lower trap‐state densities, more proficient charge dynamics, and larger built‐in potential than HT‐CsPbIBr2 PSCs. Consequently, VALT‐CsPbIBr2 PSCs deliver a higher efficiency of 11.01% accompanied by a large open‐circuit voltage of 1.289 V and a remarkable fill factor of 75.31%, being highly impressive among those reported CsPbIBr2 PSCs. By contrast, the efficiency of HT‐CsPbIBr2 PSCs is only 9.00%. Moreover, VALT‐CsPbIBr2 PSCs present stronger endurance against heat and moisture than HT‐CsPbIBr2 PSCs. Herein, a feasible avenue to fabricate efficient yet stable all‐inorganic PSCs via low‐temperature engineering is provided.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.